Koh Ai-Ling, Tan Ee-Shien, Brett Maggie S, Lai Angeline H M, Jamuar Saumya Shekhar, Ng Ivy, Tan Ene-Choo
Department of Paediatrics, KK Women's & Children's Hospital, Singapore.
Genetics Service, Department of Paediatrics, KK Women's & Children's Hospital, Singapore.
Mol Genet Genomic Med. 2019 Apr;7(4):e00581. doi: 10.1002/mgg3.581. Epub 2019 Feb 19.
Noonan syndrome (NS) is an autosomal dominant disorder that belongs to a group of developmental disorders called RASopathies with overlapping features and multiple causative genes. The aim of the study was to identify mutations underlying this disorder in patients from Southeast Asia and characterize their clinical presentations.
Patients were identified from the hospital's Genetics clinics after assessment by attending clinical geneticists. A targeted gene panel was used for next-generation sequencing on genomic DNA extracted from the blood samples of 17 patients.
Heterozygous missense variants were identified in 13 patients: eight were in PTPN11, three in SOS1, and one each in RIT1 and KRAS. All are known variants that have been reported in patients with NS. Of the 13 patients with identified variants, 10 had short stature, the most common feature for NS. Four of the eight patients with PTPN11 variants had atrial septal defect. Only two had pulmonary stenosis which is reported to be common for PTPN11 mutation carriers. Another two had hypertrophic cardiomyopathy, a feature which is negatively associated with PTPN11 mutations.
Our study provides the mutation and phenotypic spectrum of NS from a new population group. The molecular testing yield of 76% is similar to other studies and shows that the targeted panel approach is useful for identifying genetic mutations in NS which has multiple causative genes. The molecular basis for the phenotypes of the remaining patients remains unknown and would need to be uncovered via sequencing of additional genes or other investigative methods.
努南综合征(NS)是一种常染色体显性疾病,属于一组称为RAS病的发育障碍,具有重叠特征和多个致病基因。本研究的目的是确定东南亚患者中该疾病的潜在突变,并描述其临床表现。
经临床遗传学家评估后,从医院的遗传学诊所中识别出患者。使用靶向基因panel对从17名患者的血液样本中提取的基因组DNA进行二代测序。
在13名患者中鉴定出杂合错义变异:8例在PTPN11中,3例在SOS1中,1例分别在RIT1和KRAS中。所有这些都是在NS患者中已报道的已知变异。在13名鉴定出变异的患者中,10例身材矮小,这是NS最常见的特征。8例携带PTPN11变异的患者中有4例患有房间隔缺损。只有2例有肺动脉狭窄,据报道这在PTPN11突变携带者中很常见。另外2例有肥厚型心肌病,这一特征与PTPN11突变呈负相关。
我们的研究提供了一个新人群组中NS的突变和表型谱。76%的分子检测阳性率与其他研究相似,表明靶向panel方法有助于识别具有多个致病基因的NS中的基因突变。其余患者表型的分子基础仍然未知,需要通过对其他基因进行测序或其他调查方法来揭示。